Influenza virus — Drug Target

All drugs that target Influenza virus — marketed and clinical-stage. Includes 5 drug classes acting on this target.

Drug classes

Vaccine · RNA-based therapeutic · antisense oligonucleotide · RNA-based therapy · Live attenuated influenza vaccine (LAIV)

Marketed (6)

• Quadrivalent influenza modRNA vaccine · Pfizer · Vaccine · Infectious Disease
  This quadrivalent influenza modRNA vaccine uses messenger RNA to instruct cells to produce a specific protein, targeting influenza A subtype viruses and influenza B viruses.
• PF-07871987 Influenza saRNA · Pfizer · RNA-based therapeutic · Infectious Disease
• PF-07852352 Influenza saRNA 1 · Pfizer · antisense oligonucleotide · Infectious Disease
• PF-07914705 Influenza saRNA · Pfizer · RNA-based therapy · Immunology
• FluMist Quadrivalent (2017-2018) · MedImmune LLC · Live attenuated influenza vaccine (LAIV) · Immunology
  FluMist Quadrivalent is a live attenuated influenza vaccine that stimulates an immune response in the nasal passages to prevent influenza infection.
• PF-07915048 Influenza saRNA · Pfizer · RNA-based therapy · Infectious Disease